TOKYO -- Japanese trading house Mitsui & Co. will join the Japan Bank for International Cooperation to invest in a Singapore pharmaceutical startup that does the leg work of securing drug approvals and marketing rights in developing countries, a relatively untapped growth area.
Pharmaceuticals
Mitsui & Co. invests in Singapore pharma marketer Wellesta
Trading house sees growth in Asia for drugs already approved in developed world
.JPG?width=780&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto)
Mitsui & Co. hopes to tap demand for medicines in developing Asian countries, which major pharmaceutical companies sometimes pass over due to market size. © Reuters
Read Next
%2520%E3%81%AE%E3%82%B3%E3%83%94%E3%83%BC.jpg?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)
Latest on Pharmaceuticals
